Hippo pathway activation mediates chemotherapy-induced anti-cancer effect and cardiomyopathy through causing mitochondrial damage and dysfunction
Gang She(Xi'an Jiaotong University), Xiao‐Jun Du(Xi'an Jiaotong University), Ru‐Yue Bai(Xi'an Jiaotong University), Jin-Chan Du(Xi'an Jiaotong University), Zheng‐Da Pang(Xi'an Jiaotong University), Xiu‐Ling Deng(Ministry of Education), Tian-Tian Pu(Xi'an Jiaotong University), Junichi Sadoshima(Rutgers, The State University of New Jersey), Yi Zhang(University of Southern California), Yu Zhang(Jiangnan University), Hui‐Fang Wang(Xi'an Jiaotong University), Wei Wu(Xi'an Jiaotong University), Yujie Ren(Wuhan Institute of Virology)
Cited by 61
Related Papers
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k
The ORF3a protein of SARS-CoV-2 induces apoptosis in cells
|Cellular and Molecular Immunology|2020|514
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19
|Immunity|2020|387
Plasma metabolomic and lipidomic alterations associated with COVID-19
|National Science Review|2020|367